What is FLUIDDA?
FLUIDDA operates at the intersection of advanced imaging and artificial intelligence, specializing in Functional Respiratory Imaging (FRI). This proprietary methodology allows for a granular understanding of lung pathology and physiology, providing healthcare professionals with actionable insights that were previously inaccessible through traditional diagnostic modalities. By facilitating personalized medicine, FLUIDDA enables clinicians to tailor treatment pathways, thereby optimizing patient outcomes while simultaneously reducing the economic burden on healthcare providers. The company serves as a vital partner to the pharmaceutical and biotech industries, where its technology is deployed to accelerate drug development cycles and enhance the efficacy of clinical trials for respiratory conditions.
How much funding has FLUIDDA raised?
FLUIDDA has raised a total of $2M across 1 funding round:
Other Financing Round
$2M
Other Financing Round (2019): $2M with participation from Materialise
Key Investors in FLUIDDA
Materialise
Materialise is a Belgian-based pioneer in 3D printing software and services, specializing in medical imaging and additive manufacturing solutions for the healthcare sector.
What's next for FLUIDDA?
With this major enterprise-level funding, FLUIDDA is well-positioned to scale its operational footprint and deepen its integration within the global clinical research ecosystem. The strategic focus will likely shift toward expanding the reach of its FRI platform, potentially incorporating more robust AI-driven predictive analytics to further refine diagnostic accuracy. As the company matures, the emphasis will remain on fostering collaborative partnerships with major pharmaceutical entities to streamline the path from drug discovery to patient application. By maintaining its commitment to technological innovation, FLUIDDA is poised to redefine the standard of care for chronic respiratory diseases, ensuring that its diagnostic solutions remain at the forefront of the personalized medicine revolution.
See full FLUIDDA company page
